Pictured: Mark Kris, Andreas Rimner, Nabil Pierre Rizk & Max Gomez
Video
By Helen Garey, MPH, Freelance Writer  |  Tuesday, September 3, 2013

In a recent CancerSmart talk focused on lung cancer, three Memorial Sloan Kettering experts described advances in diagnosis and treatment.

Cancer Guide
By Andrea Peirce, BA, Writer/Editor  |  Friday, August 16, 2013

Memorial Sloan Kettering uses a multidisciplinary approach to provide leading-edge care to women with cervical cancer.

Pictured: Larry Norton
In the News
By Media Staff  |  Wednesday, July 31, 2013

Deputy Physician-in-Chief for Breast Cancer Programs Larry Norton was interviewed on PBS NewsHour about a recent recommendation from a National Cancer Institute working group that proposed changing the definition of cancer.

Pictured: Peter Bach
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Tuesday, July 30, 2013

A new online decision tool can help current or former smokers determine whether they would benefit from lung cancer screening.

Pictured: Low-dose chest CT scan
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Monday, June 17, 2013

Memorial Sloan Kettering now offers low-dose CT screening for certain smokers at high risk for lung cancer.

Pictured: Health & Wellness Seminar Speakers
Event
By Celia Gittelson, BA  |  Friday, May 3, 2013

More than 100 people participated in a community-based cancer health and wellness seminar sponsored by the Office of Diversity Programs as part of National Minority Cancer Awareness Month.

Pictured: Andrew Vickers
Finding
By Allyson Collins, MS, Science Writer/Editor  |  Wednesday, April 17, 2013

A study led by Memorial Sloan Kettering investigators indicates nearly half of all prostate cancer deaths by age 75 occur in a small group of men with high PSA levels at age 45.

Pictured: Megan Harlan Fleischut & Kenneth Offit
Q&A
By Julie Grisham, MS, Science Writer/Editor  |  Monday, April 15, 2013

Genetic counselor Megan Harlan Fleischut discusses hereditary cancers and the services offered by Memorial Sloan Kettering’s clinical genetics experts.

Pictured: Kenneth Offit
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, March 28, 2013

A study identifies genetic variations that alter the risk of breast cancer in women who have a certain gene mutation.

Pictured: Peter Scardino
Q&A
By Esther Napolitano, BS, Science Writer/Editor  |  Thursday, March 14, 2013

Dr. Scardino discusses strategies for how physicians and patients can make the best use of PSA testing and prostate cancer treatment.

Pictured: Mammogram
Q&A
By Media Staff  |  Wednesday, January 30, 2013

A New York State law that went into effect this month requires radiologists to inform women if they have dense breasts. Dr. Lee answers questions about the concept of breast density and what women should know.

Pictured: Charles Sawyers' Laboratory
In the Clinic
By Media Staff  |  Monday, January 7, 2013

The American Society of Clinical Oncology’s notable research advances include the approval of a new drug for men with advanced prostate cancer that was developed and studied by Memorial Sloan Kettering researchers.

Pictured: Carol Lee
Q&A
By Memorial Sloan Kettering  |  Wednesday, October 10, 2012

During Breast Cancer Awareness Month, Dr. Lee discusses mammography, breast MRI, and breast ultrasound.

Pictured: Chaya Moskowitz
In the Clinic
By Media Staff  |  Monday, June 4, 2012

A new study confirms that female childhood cancer survivors who were treated with radiation to the chest have a high risk of developing breast cancer at a young age – a risk that is comparable to that of women who have mutations in BRCA1 or BRCA2 genes.

Pictured: Howard Scher
Perspective
By Memorial Sloan Kettering  |  Friday, June 1, 2012

Memorial Sloan Kettering’s prostate cancer team — including Howard I. Scher, Chief of the Genitourinary Oncology Service — disagrees with new PSA screening recommendations released by government task force.

Center News

Stay Informed

Get the latest information about cancer care and research every month.